Journals / European Journal of Rheumatology / 2015 / Cilt: 2 - Sayı: 1

İnflamatuvar romatizmal hastalıklarda pulmoner arteriyel hipertansiyonun erken tanısı mümkün müdür? Türkiye'de tek merkez deneyimi

Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey

Pages
1–4
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a positive correlation between sPAP estimated by Doppler echocardiography and sPAP determined by RHC in patients with inflammatory rheumatic diseases (r=0.66; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pulmonary arterial hypertension (PAH) is a devastating complication of inflammatory rheumatic diseases.
📊
Key Findings & Data:All patients with inflammatory disease were evaluated by right heart catheterization (RHC) to check if they had systolic pulmonary arterial pressure (sPAP) >=40 mmHg and/or symptoms related to PH unless explained by other causes.Results: RHC was performed in 47 patients with inflammatory rheumatic diseases and PH out of 50 patients who were to be evaluated by RHC based on clinical and Doppler echocardiographic findings.
💡
Conclusion & Impact:There was a positive correlation between sPAP estimated by Doppler echocardiography and sPAP determined by RHC in patients with inflammatory rheumatic diseases (r=0.66; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Pulmonary arterial hypertension (PAH) is a devastating complication of inflammatory rheumatic diseases. The aim of this study was to determine the role of screening for the early diagnosis of pulmonary hypertension (PH) in inflammatory rheumatic diseases.Material and Methods: Data of patients with inflammatory rheumatic diseases and PH who had no obvious cause of PH and who were evaluated by Working Group for Pulmonary Hypertension in Hacettepe University were investigated retrospectively. All patients with inflammatory disease were evaluated by right heart catheterization (RHC) to check if they had systolic pulmonary arterial pressure (sPAP) >=40 mmHg and/or symptoms related to PH unless explained by other causes.Results: RHC was performed in 47 patients with inflammatory rheumatic diseases and PH out of 50 patients who were to be evaluated by RHC based on clinical and Doppler echocardiographic findings. There was a positive correlation between sPAP estimated by Doppler echocardiography and sPAP determined by RHC in patients with inflammatory rheumatic diseases (r=0.66; p

Özet

Amaç: Pulmoner arteriyel hipertansiyon (PAH) inflamatuvar romatizmal hastalıkların yıkıcı bir komplikasyonudur. Bu çalışmanın amacı inflamatuvar romatizmal hastalıklarda pulmoner hipertansiyon (PH) erken tanısı için taramanın rolünü değerlendirmekti. Materyal ve Metot: İnflamatuvar romatizmal hastalığı ve PH'si olan, belirgin PH nedeni olmayan ve Hacettepe Üniversitesi Pulmoner Hipertansiyon Çalışma Grubu tarafından değerlendirilen hastaların verileri retrospektif olarak incelendi. İnflamatuvar hastalığı olan tüm hastalar, sistolik pulmoner arteriyel basınç (sPAB)'larının >=40 mmHg olup olmadığını ve/veya başka nedenlerle açıklanmayan PH ilişkili semptomlarının olup olmadığını kontrol etmek için sağ kalp kateterizasyonu (SKK) ile değerlendirildi. Bulgular: İnflamatuvar romatizmal hastalığı ve PH'si olan klinik ve Doppler ekokardiyografik bulgulara göre SKK ile değerlendirilecek olan 50 hastadan 47'sine SKK uygulandı. İnflamatuvar romatizmal hastalığı olan hastalarda, Doppler ekokardiyografi ile hesaplanan sPAB ile SKK ile belirlenen sPAB arasında pozitif korelasyon vardı (r=0.66; p

🔖

Cite This Article

KILIÇ, L., EVRANOS, B., ÇÖPLÜ, L., ÇALGÜNERİ, M., ERTENLİ, İ., OTO, A., OKUTUCU, S., KAYA, B., TOKGÖZOĞLU, L., AYTEMİR, K., AKDOĞAN, A. (2022). İnflamatuvar romatizmal hastalıklarda pulmoner arteriyel hipertansiyonun erken tanısı mümkün müdür? Türkiye'de tek merkez deneyimi. European Journal of Rheumatology, Cilt: 2 - Sayı: 1, 1–4. https://ajindex.com/articles/511807

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Carreira PE. Pulmonary hypertension in auto- immune rheumatic diseases. Autoimmun Rev 2004
  2. [CrossRef] Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. J Am Coll Cardiol 2011
  3. [CrossRef] Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, et al. Prognos- tic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995
  4. [CrossRef] Bonderman D, Wilkens H, Wakounig S, Schäfers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hyperten- sion. Eur Respir J 2009
  5. [CrossRef] Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008
  6. [CrossRef] Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hyper- tension. Eur Respir J 2009
  7. [CrossRef] Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of sys- temic sclerosis: a report from the EULAR Sclero- derma Trials and Research group (EUSTAR). Ann Rheum Dis 2009
  8. [CrossRef] Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hyperten- sion. The Task Force on Diagnosis and Treat- ment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004
  9. [CrossRef] Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pul- monary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003
  10. [CrossRef] Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmo- nary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005
  11. [CrossRef] Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiag- nosed pulmonary arterial hypertension in sub- jects with connective tissue disease at the sec- ondary health care level of community-based rheumatologists (the UNC